Identification of Molecular Markers of Clozapine Action in Ketamine-Induced Cognitive Impairment: A GPCR Signaling PathwayFinder Study

Background: Cognitive disorders associated with schizophrenia are closely linked to prefrontal cortex (PFC) dysfunction. Administration of the non-competitive NMDA receptor antagonist ketamine (KET) induces cognitive impairment in animals, producing effects similar to those observed in schizophrenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Korlatowicz, Agata, Kuśmider, Maciej, Szlachta, Marta, Pabian, Paulina, Solich, Joanna, Dziedzicka-Wasylewska, Marta, Faron-Górecka, Agata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621432/
https://www.ncbi.nlm.nih.gov/pubmed/34830086
http://dx.doi.org/10.3390/ijms222212203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621432/
https://www.ncbi.nlm.nih.gov/pubmed/34830086
http://dx.doi.org/10.3390/ijms222212203

Ejemplares similares